Trials / Unknown
UnknownNCT05086458
Impact of Probiotics Supplement on the Gut Microbiota in Caesarean-born Infants
Impact of Probiotics Supplement on the Gut Microbiota in Caesarean-born Infants: an Open-label Single-center Randomized Parallel Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 1 Hour – 42 Days
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effect of probiotics on the gut microbiota of infants born by cesarean section.
Detailed description
This study aims to examine the impact of probiotics administration on the gut microbiota of infants born by cesarean section. Birth,14 days and 42 days data will be collected and put into analysis to provide some suggestions on the probiotics use in the clinical for the infants born by cesarean section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | probiotics | probiotics blend of Bifidobacterium longum, Lactobacillus acidophilus, Enterococcus faecalis |
Timeline
- Start date
- 2021-08-17
- Primary completion
- 2021-10-17
- Completion
- 2021-10-17
- First posted
- 2021-10-21
- Last updated
- 2021-10-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05086458. Inclusion in this directory is not an endorsement.